About PHPBiotech.wiki
Short answer: PHPBiotech.wiki is a reference about PHP Biotech, written by the PHP Biotech Wiki editorial team and produced by a marketing agency that works for PHP Biotech. It is compiled from public sources, it is not the company’s official website, it is not reviewed by any regulator and nothing on it is medical advice.
Who writes this wiki?
The PHP Biotech Wiki editorial team. The site is produced by a marketing agency that works for PHP Biotech, so it has a commercial relationship with the company it describes. To keep it useful, every fact is cited, the company’s own statements are attributed to the company, and conflicting or unfavorable records, such as differing addresses and pending patent status, are reported as shown.
What does this wiki cover?
The company’s drug candidate, platform, development stage, patents, publications, people, history and corporate records, using ClinicalTrials.gov, PubMed, patent publications, registries, the Internet Archive, press releases and the company’s website. See Sources.
What does this wiki not do?
- It does not give medical advice or suggest that PHP53-nb treats any disease; PHP53-nb is a preclinical research product.
- It does not describe laboratory or animal results as if they applied to people.
- It does not speak for PHP Biotech, any regulator or any journal.
- It does not include anything it could not source.
What is still unverified?
These questions are open and nothing about them is stated as fact on this site. This wiki is asking the company to clarify them:
- Headquarters. Which address is the official headquarters: Southlake, Texas (website), Keller, Texas (2024 paper and 2024 website), or Botucatu, Brazil (Brazilian registry)?
- Incorporation. The state or country where PHP Biotech International Inc. is incorporated, and its registry file number. No entry was found in Texas open data, and the paid Texas and CAPTCHA-protected Delaware searches were not used.
- US and Brazilian companies. How PHP Biotech International Inc. relates to PHP Biotech Pesquisa e Desenvolvimento S.A. (CNPJ 40.622.810/0001-02), which shares six officers with the company roster.
- Founding date. When PHP Biotech International Inc. was founded. The company website gives only relative years; the Brazilian company opened on 29 January 2021.
- Development-stage wording. Three biographies on the company website use the term “clinical-stage”, while registry records and the company’s science pages show preclinical work. This wiki describes the company as preclinical.
- Pepcrotament. Whether Pepcrotament, the name used on the 2024 website, is the earlier name of PHP53-nb.
- Molecule size. Whether PHP53-nb is about 17 kDa (current pages) or about 14 kDa (January 2026 website).
- Patents. Whether any patent has been granted, and what the two unpublished applications of the “four U.S. patent applications” cover.
- Phone number. The company’s public phone number; the number in its September 2026 press releases is a placeholder.
- Unpublished data. Whether the zebrafish, mouse, pancreatic and ovarian cell, and uPAR receptor results have been published or presented anywhere citable.
- Titles. Current titles of Moacyr Bighetti, Eduardo Braun and Fabio Jung, which differ between the website and a September 2026 press release, and the role of Marcelo Baruffi, PhD, named in that release.
- Funding. Who has invested in the company and how much; no SEC filings were found.
- Team size. The number of employees.
- Path to the clinic. Any public regulatory milestone, such as an investigational new drug application or trial registration, behind the hope of starting clinical trials in 2027.
How do I report an error?
Check the record at its source first; links are in the references on each page. Questions about the company or its research should go to PHP Biotech at contact@phpbiotech.com or through phpbiotech.com. Questions about your own health should go to a doctor. Corrections to this wiki are recorded in the changelog.